202114-63-4

202114-63-4 structure

Name: Ethyl linoleate-13C18
Chemical Name: Linoleic Acid-13C18 ethyl ester
CAS Number: 202114-63-4
Molecular Formula: C₂₁₃C₁₈H₃₆O₂
Molecular Weight: 326.366
Catalog: Research Areas Cardiovascular Disease
Create Date: 2021-04-16 11:06:05
Modify Date: 2024-01-12 12:47:15
Ethyl linoleate-13C18 (Linoleic Acid-13C18 ethyl ester) is the 13C labeled Ethyl linoleate. Ethyl linoleate inhibit the development of atherosclerotic lesions and the expression of inflammatory mediators[1].

Name	Linoleic Acid-13C18 ethyl ester
Synonyms	Linoleic Acid-13C18 ethyl ester Ethyl (9Z,12Z)-(13C18)-9,12-octadecadienoate 9,12-Octadecadienoic-1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-13C18 acid, ethyl ester, (9Z,12Z)-

Description	Ethyl linoleate-13C18 (Linoleic Acid-13C18 ethyl ester) is the 13C labeled Ethyl linoleate. Ethyl linoleate inhibit the development of atherosclerotic lesions and the expression of inflammatory mediators[1].
Related Catalog	Research Areas >> Cardiovascular Disease Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.